Nils’ Story: A Passion for Discovery and Changing the Way Cancer is Treated

Feb 16, 2016 10:15 AM ET

Discovery is in Nils’ DNA. His fascination with chemistry labs began as child, when he tagged along with his father, who was a graduate student at the University of California. As a graduate student at Harvard, Nils learned about a new technology for manipulating the genome of mammals, and was so intrigued that he continued this field of study in a postdoctoral fellowship at Memorial Sloan Kettering Cancer Center in New York. Today, at Bristol-Myers Squibb, Nils leads a drug discovery group responsible for looking for new medicines to help patients overcome serious diseases. He continues to follow his passion: working with a team of dedicated scientists on research that has the potential to change the way cancer is treated.

Join Bristol-Myers Squibb Online:

Website: http://www.bms.com

Twitter: http://www.twitter.com/BMSnews

LinkedIn: https://www.linkedin.com/company/bristol-myers-squibb

YouTube: https://www.youtube.com/channel/UCjFf4oKibYrHae2NZ_GPS6g

Nils’ Story: A Passion for Discovery and Changing the Way Cancer is Treated

More from Bristol Myers Squibb Company

One Community at a Time: Enabling Early Lung Cancer Detection Across the U.S.

Bristol Myers Squibb Promotes Health Equity with 100 Percent of Marketed Products Now Supported by Access Plans

Bristol Myers Squibb's Commitment to Environment, Social and Governance: Our Progress & Aspirational Goals

Bristol Myers Squibb Reaches Major Milestone in Environmental Sustainability

BMS Named 2024 Best Place to Work for Disability Inclusion in US, UK and Brazil by the Disability Equality Index®

Bristol Myers Squibb Named to Dow Jones Sustainability Index North America

ASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income Countries

Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries